Case studies showing clinical signs and management of cutane…
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1%2F2 inhibitor AZD6244 %28ARRY-142886%29 in patients with solid tumours.
Article, Chapter
Authors:
I.M.E. Desar
Publication:
Volume:49,
Issue:1
Published:
2010
ISSN:
0284-186X
We were unable to find direct full text links for this item.